Pr Caroline Robert
Head of the Dermatology department and Inserm Research Director at Gustave Roussy
Professor at Paris-Saclay University
Pr Xavier Mariette
Head of the Rheumatology department and Inserm research director at Bicêtre Hospital (AP-HP)
Professor at Paris-Saclay University
The coordination office ensures the smooth running of the DIM ITAC, both administratively and scientifically. It is made up of the DIM coordinators and a project manager in charge of the operational coordination of the DIM (management of calls for projects, communication, liaison with administrative support services and Paris Region).
Xavier MARIETTE
Caroline ROBERT
Nora YAHIA, cheffe de projet, Gustave Roussy
The Scientific Advisory Board is made up of the scientific sponsors of the DIM and experts from the Paris Region in the fields covered by the DIM. A representative appointed by the region is a permanent guest of the Scientific Council, without voting rights. The Scientific Advisory Board makes scientific policy recommendations to the Board of Directors based on the interests and collective direction of the DIM ITAC. It evaluates applications for funding in response to the various calls for projects.
> Sébastien AMIGORENA – Unité U932 – Institut Curie – PARIS
> Philippe BOUSSO – Inserm U1223 – Institut Pasteur – PARIS
> Eleonora DEMARTIN – Centre Hépato Biliaire – Hôpital Paul Brousse – VILLEJUIF
> Stéphane EDERHY – Service de Cardiologie et maladies vasculaires – Hôpital Saint Antoine – PARIS
> Guy GOROCHOV – Inserm U1135 – Hôpital de la Pitié Salpêtrière, AP-HP – PARIS
> Olivier HERMINE – Service d’Hématologie – Hôpital Necker – Institut Imagine – PARIS
> Frederik JOLY – Coexya – LYON
> Olivier LAMBOTTE – Service de Médecine Interne et Immunologie – Hôpital Bicêtre – IMVA IDMIT – CEA – KREMLIN BICETRE
> Roger LEGRAND – Inserm U1184 IMVA IDMIT – CEA – FONTENAY AUX ROSES
> Patricia LEPAGE – UMR 1319 MICALIS Institute – AgroParis Tech – INRAE – JOUY EN JOSAS
> Aurélien MARABELLE – Inserm CIC1428 – Inserm 1015 – Gustave Roussy – VILLEJUIF
> Xavier MARIETTE – Service de Rhumatologie – Hôpital Bicêtre – IMVA, CEA – KREMLIN BICETRE
> Philippe MOINGEON – Servier – PARIS
> Luc MOUTHON – Centre de référence maladies systémiques auto-immunes rares d’Île-de-France – Inserm U1016 – Institut Cochin – PARIS
> Jean-Luc PERFETTINI – Inserm UMR1030 – Gustave Roussy – VILLEJUIF
> Caroline ROBERT – Service de Dermatologie – INSERM U981 – Gustave Roussy – VILLEJUIF
> Marc-Michel ROHE – Guerbet – VILLEPINTE
> Jean-Yves SCOAZEC – CNRS UMS 3655 AMMICA – Gustave Roussy – VILLEJUIF
> Mehdi TOUAT – CNRS UMR 7225 – Inserm U1127 – ICM – PARIS
> Céline VERSTUYFT – CRB Paris Saclay – Hôpital Bicêtre – KREMLIN BICETRE
> Zahia ZAIDAT – Région Île-de-France – PARIS
> Laurence ZITVOGEL – UMR 1015 Clinic Obiome – Gustave Roussy – VILLEJUIF
The Board of Directors is made up of the DIM’s coordinators, representatives of the member institutions and players from the socio-economic world. A representative appointed by the Paris Region is a permanent guest on the Board, without voting rights. The Board decides on DIM ITAC’s scientific and budgetary strategy. In the context of calls for projects, it selects the projects to be funded on the recommendation of the Scientific Council.
Sophie BEAUPERE – UniCancer – PARIS
Paul-Henry COURNEDE – Centrale Supelec – GIF-SUR-YVETTE
Christian DELEUZE – Sanofi – PARIS
Erik DOMAIN – AP-HP – PARIS
Christel DUBROCA – Gustave Roussy – VILLEJUIF
Marc HUMBERT – Paris Saclay – KREMLIN BICETRE
Nicole KEFFACHE – CNRS – PARIS
Stéphane LE CROM – Sorbonne Université – PARIS
Tatiana MALHERBE – Institut Curie – PARIS
Xavier MARIETTE – AP-HP – KREMLIN BICETRE
Anne PAOLETTI – Gustave Roussy – VILLEJUIF
Marie-Hélène PAPILLON – CNRS – PARIS
Laurence PARMENTIER – INSERM – PARIS
Caroline ROBERT – Gustave Roussy – VILLEJUIF
Nathalie TOUZE – INRAE – JOUY EN JOSAS
Reiner VEITIA – CEA – FONTENAY AUX ROSES
Romain VIDAL – Région IDF – SAINT OUEN
Zahia ZAIDAT – Région IDF – SAINT OUEN
Membres suppléants :
Angélique BIOCOTTO – Sanofi – PARIS (représentante Mr Deleuze)
Adrien BOUSSAGUET – CNRS – PARIS (représentant Mme Papillon)
Muriel DAHAN – UniCancer – PARIS (représentante Mme Beaupère)
Yvan DE LAUNOIT – CNRS – PARIS (représentant Mme Papillon)
Tania DI GIOA – Paris Saclay – KREMLIN BICETRE (représentante Mr Humbert)
Alain EYCHENE – INSERM (représentant Mr Parmantier)
Anne-Laure MARTIN – UniCancer – PARIS (représentante Mme Beaupère)
Lydie MAUVISSEAU – Paris Saclay – KREMLIN BICETRE (représentante Mr Humbert)
The CEE is composed of reviewers from outside the ITAC DIM whose expertise covers the scientific scope of the DIM (cancer, autoimmunity, immunotherapies). Their role is to evaluate projects submitted in response to calls for proposals.